Alan Skarbnik, MD, serves as the director of the lymphoma and chronic lymphocytic leukemia program and director of experimental therapeutics, malignant hematology at Novant Health. Prior to joining Novant Health, Dr. Skarbnik served as the director of the chronic lymphocytic leukemia program at John Theurer Cancer Center at Hackensack University Medical Center. As an expert in chronic lymphocytic leukemia (CLL) and lymphomas, his research focuses on using immunotherapy to improve outcomes of autologous stem cell transplantation for patients with high-risk blood cancers. Dr. Skarbnik is a member of the medical advisory board to the CLL Society and has over 90 peer-reviewed research manuscripts and abstracts in the fields of lymphomas, CLL and stem cell transplantation. Dr. Skarbnik is fluent in English, Spanish and Portuguese. During his free time, he enjoys time with his wife and three children, playing in a rock band and crafting beer.
Special Interests: Malignant Hematology, Lymphoma, Cellular Therapy, CAR-T, Chronic Lymphocytic Leukemia
Additional Languages Spoken: Portuguese, Spanish